Last reviewed · How we verify

Anesthesia induction

Second Affiliated Hospital of Xi'an Jiaotong University · FDA-approved active Small molecule

Anesthesia induction refers to the initiation phase of general anesthesia, typically using intravenous agents to rapidly induce unconsciousness and loss of protective airway reflexes.

Anesthesia induction refers to the initiation phase of general anesthesia, typically using intravenous agents to rapidly induce unconsciousness and loss of protective airway reflexes. Used for Induction of general anesthesia for surgical procedures, Rapid sequence intubation in emergency settings.

At a glance

Generic nameAnesthesia induction
SponsorSecond Affiliated Hospital of Xi'an Jiaotong University
ModalitySmall molecule
Therapeutic areaAnesthesiology
PhaseFDA-approved

Mechanism of action

Anesthesia induction is a procedural approach rather than a single drug entity. It commonly employs intravenous agents such as propofol, thiopental, or etomidate that act on central nervous system receptors (primarily GABA receptors) to produce rapid onset of unconsciousness. The choice of agent depends on patient factors, surgical requirements, and institutional protocols.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: